Clinical Trial Update: Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a human monoclonal antibody targeting C. difficile toxins A and B in patients with Clostridium difficile-associated disease has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection
• Clostridium Difficile-associated Disease

Drugs mentioned

• massbiologics monoclonal antibody (unnamed in snippet) (human monoclonal antibody to C. difficile toxin A and toxin B)

Snippet

Sponsor: MassBiologics | Conditions: Clostridium Infections | Phase 2 | Status: COMPLETED | Results posted: 2021-02-09